International Medicine and Health Guidance News ›› 2024, Vol. 30 ›› Issue (1): 15-20.DOI: 10.3760/cma.j.issn.1007-1245.2024.01.003
• New Medical Advances • Previous Articles Next Articles
Research progress on diabetic nephropathy complicated with pregnancy
Chen Wenqing, Guan Baozhang
Department of Nephrology, First Hospital, Jinan University, Guangzhou 510000, China
Received:
2023-08-25
Online:
2024-01-01
Published:
2024-02-01
Contact:
Guan Baozhang, Email: guanbaozhang130@163.com
Supported by:
Program of Science and Technology in Guangzhou (202201020068)
糖尿病肾病合并妊娠研究进展
陈文清 管保章
暨南大学附属第一医院肾内科,广州 510000
通讯作者:
管保章,Email:guanbaozhang130@163.com
基金资助:
广州市科技计划(202201020068)
Chen Wenqing, Guan Baozhang.
Research progress on diabetic nephropathy complicated with pregnancy [J]. International Medicine and Health Guidance News, 2024, 30(1): 15-20.
陈文清 管保章.
糖尿病肾病合并妊娠研究进展 [J]. 国际医药卫生导报, 2024, 30(1): 15-20.
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.imhgn.com/EN/10.3760/cma.j.issn.1007-1245.2024.01.003
[1] Kitzmiller JL, Wallerstein R, Correa A, et al. Preconception care for women with diabetes and prevention of major congenital malformations [J]. Birth Defects Res A Clin Mol Teratol, 2010, 88(10): 791-803. DOI: 10.1002/bdra.20734. [2] Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study [J]. Diabetes Care, 2009, 32(11): 2005-2009. DOI: 10.2337/dc09-0656. [3] Gordon M, Landon MB, Samuels P, et al. Perinatal outcome and long-term follow-up associated with modern management of diabetic nephropathy [J]. Obstet Gynecol, 1996, 87(3): 401-409. DOI: 10.1016/0029-7844(95)00420-3. [4] Dunne FP, Chowdhury TA, Hartland A, et al. Pregnancy outcome in women with insulin-dependent diabetes mellitus complicated by nephropathy [J]. QJM, 1999, 92(8): 451-454. DOI: 10.1093/qjmed/92.8.451. [5] Bramham K. Diabetic nephropathy and pregnancy [J]. Semin Nephrol, 2017, 37(4):362-369. DOI: 10.1016/j.semnephrol.2017.05.008. [6] Podymow T, Joseph G. Preconception and pregnancy management of women with diabetic nephropathy on angiotensin converting enzyme inhibitors [J]. Clin Nephrol, 2015, 83(2): 73-79. DOI: 10.5414/CN108391. [7] Carr DB, Koontz GL, Gardella C, et al. Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery [J]. Am J Hypertens, 2006, 19(5): 513-519. DOI: 10.1016/j.amjhyper.2005.12.010. [8] Mathiesen ER, Ringholm L, Feldt-Rasmussen B, et al. Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment [J]. Clin J Am Soc Nephrol, 2012, 7(12): 2081-2088. DOI: 10.2215/CJN.00920112. [9] Ekbom P, Damm P, Feldt-Rasmussen B, et al. Pregnancy outcome in type 1 diabetic women with microalbuminuria [J]. Diabetes Care, 2001, 24(10): 1739-1744. DOI: 10.2337/diacare.24.10.1739. [10] Kendrick JM. Preconception care of women with diabetes [J]. J Perinat Neonatal Nurs, 2004, 18(1): 14-25; quiz 26-27. DOI: 10.1097/00005237-200401000-00003. [11] Young EC, Pires ML, Marques LP, et al. Effects of pregnancy on the onset and progression of diabetic nephropathy and of diabetic nephropathy on pregnancy outcomes [J]. Diabetes Metab Syndr, 2011, 5(3): 137-142. DOI: 10.1016/j.dsx.2012.02.013. [12] Aldhaheri S, Baghlaf H, Badeghiesh A, et al. Should pregnant women with diabetes be counseled differently if nephropathy was detected? a population database study [J]. J Matern Fetal Neonatal Med, 2022, 35(25): 9614-9621. DOI: 10.1080/14767058.2022.2049749. [13] Kornacki J, Boroń D, Gutaj P, et al. Diagnosis of preeclampsia in women with diabetic kidney disease [J]. Hypertens Pregnancy, 2021, 40(4): 322-329. DOI: 10.1080/10641955.2021.1987454. [14] Bell R, Glinianaia SV, Tennant PW, et al. Peri-conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study [J]. Diabetologia, 2012. DOI: 10.1007/s00125-012-2455-y. [15] Klemetti MM, Laivuori H, Tikkanen M, et al. Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011 [J]. Diabetologia, 2015, 58(4): 678-686. DOI: 10.1007/s00125-014-3488-1. [16] Sibiak R, Gutaj P, Mrzewka-Rogacz B, et al. Novel continuous glucose monitoring metrics and large-for-gestational-age risk: an exploratory retrospective cohort study in pregnancies with type 1 diabetes [J]. Diabetes Technol Ther, 2022, 24(1): 42-53. DOI: 10.1089/dia.2021.0194. [17] Søholm JC, Vestgaard M, Ásbjörnsdóttir B, et al. Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes [J]. Diabetologia, 2021, 64(9): 1939-1948. DOI: 10.1007/s00125-021- 05482-8. [18] Kerssen A, Evers IM, de Valk HW, et al. Poor glucose control in women with type 1 diabetes mellitus and 'safe' hemoglobin A1c values in the first trimester of pregnancy [J]. J Matern Fetal Neonatal Med, 2003, 13(5): 309-313. DOI: 10.1080/jmf.13.5.309.313. [19] Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors [J]. N Engl J Med, 2006, 354(23): 2443-2451. DOI: 10.1056/NEJMoa055202. [20] Kennedy D, Koren G. Identifying women who might benefit from higher doses of folic acid in pregnancy [J]. Can Fam Physician, 2012, 58(4): 394-397. [21] Chitayat D, Matsui D, Amitai Y, et al. Folic acid supplementation for pregnant women and those planning pregnancy: 2015 update [J]. J Clin Pharmacol, 2016, 56(2): 170-175. DOI: 10.1002/jcph.616. [22] Wilson RD, Genetics Committee, Wilson RD, et al. Pre-conception folic acid and multivitamin supplementation for the primary and secondary prevention of neural tube defects and other folic acid-sensitive congenital anomalies [J]. J Obstet Gynaecol Can, 2015, 37(6): 534-552. DOI: 10.1016/s1701-2163(15)30230-9. [23] Tsakiridis I, Mamopoulos A, Athanasiadis A, et al. Management of pregestational diabetes mellitus: a comparison of guidelines [J]. J Matern Fetal Neonatal Med, 2022, 35(3): 423-432. DOI: 10.1080/14767058. 2020.1719481. [24] Spotti D. Pregnancy in women with diabetic nephropathy [J]. J Nephrol, 2019, 32(3):379-388. DOI: 10.1007/s40620-018-0553-8. [25] Fu J, Tomlinson G, Feig DS. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis [J]. Diabetes Metab Res Rev, 2021, 37(8):e3453. DOI: 10.1002/dmrr.3453. [26] Li DK, Yang C, Andrade S, et al. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study [J]. BMJ. 2011 Oct 18;343:d5931. doi: 10.1136/bmj.d5931. PMID: 22010128; PMCID:PMC3196564. [27] Pearson DW, Kernaghan D, Lee R, et al. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus [J]. BJOG, 2007,114(1): 104-107. DOI 10.1111/j.1471-0528.2006.01145.x. [28] Jensen DM, Korsholm L, Ovesen P, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes [J]. Diabetes Care, 2009, 32(6):1046-1048. DOI: 10.2337/dc08-2061. [29] Galindo A, Burguillo AG, Azriel S, et al. Outcome of fetuses in women with pregestational diabetes mellitus [J]. J Perinat Med, 2006, 34(4): 323-331. DOI: 10.1515/JPM.2006.062. [30] Greene MF, Hare JW, Cloherty JP, et al. First-trimester hemoglobin A1 and risk for major malformation and spontaneous abortion in diabetic pregnancy [J]. Teratology, 1989, 39(3): 225-231. DOI: 10.1002/tera. 1420390303. [31] Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands [J]. BMJ, 2004, 328(7445): 915. DOI: 10.1136/bmj.38043.583160.EE. [32] Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes [J]. Hypertens Pregnancy, 2014, 33(1): 81-92. DOI: 10.3109/10641955.2013.837175. [33] Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study [J]. Diabetes Care, 2004, 27(12): 2819-2823. DOI: 10.2337/diacare.27.12.2819. [34] Casson IF. Pregnancy in women with diabetes--after the CEMACH report, what now? [J]. Diabet Med, 2006, 23(5): 481-484. DOI: 10.1111/j.1464-5491.2006.01896.x. [35] Kitzmiller JL, Block JM, Brown FM, et al. Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care [J]. Diabetes Care, 2008, 31(5): 1060-1079. DOI: 10.2337/dc08-9020. [36] Crowther CA, Alsweiler JM, Hughes R, et al. Tight or less tight glycaemic targets for women with gestational diabetes mellitus for reducing maternal and perinatal morbidity? (TARGET): study protocol for a stepped wedge randomised trial [J]. BMC Pregnancy Childbirth, 2018, 18(1):425. DOI: 10.1186/s12884-018-2060-2. [37] Patti AM, Giglio RV, Pafili K, et al. Advances in pharmacological treatment of type 1 diabetes during pregnancy [J]. Expert Opin Pharmacother, 2019, 20(8): 983-989. DOI: 10.1080/14656566.2019.1593372. [38] Alexopoulos AS, Blair R, Peters AL. Management of preexisting diabetes in pregnancy: a review [J]. JAMA, 2019, 321(18): 1811-1819. DOI: 10.1001/jama. 2019.4981. [39] Ringholm L, Damm JA, Vestgaard M, et al. Diabetic nephropathy in women with preexisting diabetes: from pregnancy planning to breastfeeding [J]. Curr Diab Rep, 2016, 16(2): 12. DOI: 10.1007/s11892-015-0705-3. [40] Gowda RM, Khan IA, Mehta NJ, et al. Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations [J]. Int J Cardiol, 2003, 88(2-3): 129-133. DOI: 10.1016/s0167-5273(02)00601-0. [41] Khandelwal M, Kumanova M, Gaughan JP, et al. Role of diltiazem in pregnant women with chronic renal disease [J]. J Matern Fetal Neonatal Med, 2002, 12(6): 408-412. DOI: 10.1080/jmf.12.6.408.412. [42] Lewis H, Egerman R, Kazory A, et al. Diabetes and pregnancy: risks and opportunities [J]. Cleve Clin J Med, 2018, 85(8): 619-628. DOI: 10.3949/ccjm.85a.16138. [43] American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes-2018 [J]. Diabetes Care, 2018, 41 Suppl 1: S137-S143. DOI: 10.2337/dc18-S013. [44] James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) [J]. JAMA, 2014, 311(5): 507-520. DOI: 10.1001/jama.2013.284427. [45] Weber-Schoendorfer C, Hannemann D, Meister R, et al. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study [J]. Reprod Toxicol, 2008, 26(1): 24-30. DOI: 10.1016/j.reprotox.2008.05.065. [46] Magee LA, CHIPS Study Group, von Dadelszen P, et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial [J]. BJOG, 2016, 123(7): 1143-1151. DOI: 10.1111/1471-0528. 13569. [47] Firoz T, Magee LA, MacDonell K, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review [J]. BJOG, 2014, 121(10): 1210-1218, discussion 1220. DOI: 10.1111/1471-0528.12737. [48] Rothberger S, Carr D, Brateng D, et al. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth [J]. Am J Hypertens, 2010, 23(11): 1234-1240. DOI: 10.1038/ajh.2010.159. [49] Askie LM, Duley L, Henderson-Smart DJ, et al. Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data [J]. Lancet, 2007, 369(9575):1791-1798. DOI: 10.1016/S0140-6736(07)60712-0. [50] Hu X, Liu W, Yan Y, et al. Vitamin D protects against diabetic nephropathy: Evidence-based effectiveness and mechanism [J]. Eur J Pharmacol, 2019, 845: 91-98. DOI: 10.1016/j.ejphar.2018.09.037. [51] Plum LA, Zella JB. Vitamin D compounds and diabetic nephropathy [J]. Arch Biochem Biophys, 2012, 523(1): 87-94. DOI: 10.1016/j.abb.2012.02.008. [52] Galuška D, Pácal L, Kaňková K. Pathophysiological implication of vitamin D in diabetic kidney disease [J]. Kidney Blood Press Res, 2021, 46(2): 152-161. DOI: 10.1159/000514286. |
[1] |
Liu Jin, Wang Zhenzhen, Wang Hui, Xu Chen, Yue Qingling.
Effect of hysteroscopic cervical "thumbtack" resection on pregnancy outcomes in patients with high-grade cervical squamous intraepithelial lesions [J]. International Medicine and Health Guidance News, 2023, 29(16): 2273-2276. |
[2] |
Zhou Hongming, Li Yunyi, Li Weilong, Song Zhuoheng, Chen Yu, Cao Rui, Hu Bo, Luan Shaodong, Yin Lianghong.
Advances in the application of machine learning in hemodialysis treatment [J]. International Medicine and Health Guidance News, 2023, 29(13): 1777-1781. |
[3] |
Geng Jingjing, Ren Lili, Li Xinrui.
Application of traditional Chinese medicine characteristic nursing combined with continuous health guidance in patients with early diabetic kidney disease and deficiency of both qi and yin [J]. International Medicine and Health Guidance News, 2023, 29(10): 1454-1458. |
[4] | Mei Jiahui, Lou Huankun, Wang Xun, Han Cuimin, Li Peng, Xing Tuanjie, Wang Minglang, Wang Yilian. Association between ApoE gene polymorphism and ADMA level in patients with chronic kidney disease [J]. International Medicine and Health Guidance News, 2022, 28(8): 1047-1052. |
[5] | Wei Feiyuan, Guo Junjun, Gu Juan, Wu Dongming, Xue Leyi, Wang Lingzhen, Tang Fang, Deng Lili. Investigation and analysis of the demands for popular science and health information in patients with chronic kidney disease [J]. International Medicine and Health Guidance News, 2022, 28(8): 1052-1057. |
[6] | Li Rugang, Huang Jieping, Kuang Shuanghong, Liang Zezhi, Zhong Jinghua. Clinical observation on the effect of sodium zirconium cyclosilicate powder on short-term potassium lowering in patients with severe hyperkalemia of chronic kidney disease [J]. International Medicine and Health Guidance News, 2022, 28(6): 854-858. |
[7] | Zhou Mei, Mo Yingyin, Dong Xiaojing, Liu Genghua. Analysis of correlation between TCM constitutions and risk of gestational diabetes mellitus based on theory of preventing diseases in TCM [J]. International Medicine and Health Guidance News, 2022, 28(5): 676-679. |
[8] | Gao Min, Li Qijun, Jiang Wengong, Lyu Lu. Relationship between red blood cell distribution width and left ventricular diastolic dysfunction in patients with chronic kidney diseases [J]. International Medicine and Health Guidance News, 2022, 28(4): 453-458. |
[9] | He Yanjuan, Zeng Lihong, Zhao Lihui, Huang Jiali. Effects of mindfulness cognition combined with self-compassion intervention on depression and post-traumatic growth of pregnant women induced by fetal malformation [J]. International Medicine and Health Guidance News, 2022, 28(21): 3041-3046. |
[10] | Bai Hehe, Jiang Minghuan, Peng Lirong, Nie Xiaojing, Wang Jinping, Ma Li, Xia Li. Current status and influencing factors of medication adherence in patients with non-dialysis chronic kidney disease [J]. International Medicine and Health Guidance News, 2022, 28(17): 2414-2419. |
[11] | Wang Jiao, Zhang Haiyan, Zhang Qi, Liu Hongchao, Hu Xueping. Summary of best evidences of dietary quality management in stage 5 CKD patients undergoing hemodialysis [J]. International Medicine and Health Guidance News, 2022, 28(16): 2351-2355. |
[12] | Huang Sihua. Assessment of endogenous markers of glomerular function [J]. International Medicine and Health Guidance News, 2022, 28(14): 2056-2061. |
[13] | Ou Youliang, Zhang Jun, Zhou Yanli, Xiao Chaoqun, Wu Yuyu, Du Pingping. Application effect of Family Assessment Device in pre-examination triage of pregnant women's psychological state during the epidemic [J]. International Medicine and Health Guidance News, 2022, 28(13): 1820-1824. |
[14] | Chen Hui, Yu Hui. Inhibitory effect and mechanism of sodium citrate on calcification of mouse vascular smooth muscle cells induced by high phosphorus [J]. International Medicine and Health Guidance News, 2021, 27(6): 861-868. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||